Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
Sponsor: Regeneron Pharmaceuticals
Amyotrophic Lateral Sclerosis (ALS) · Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Australia, Belgium, Canada, Germany, Japan +4 more
- Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MSCompleted
Sponsor: Kessler Foundation
Multiple Sclerosis
United States
- FES: Effect on Walking in the Real World and Participation in Daily Life in People With Multiple Sclerosis.Not Yet Recruiting
Sponsor: University of California, San Francisco
Multiple Sclerosis
United States
Sponsor: IRCCS San Raffaele
Multiple Sclerosis · Alzheimer Disease · Parkinson Disease · Migraine
Italy
Sponsor: Johns Hopkins University
Multiple Sclerosis
United States
Sponsor: Vidya Therapeutics Inc
Multiple Sclerosis
Australia
Sponsor: University of Alabama at Birmingham
Multiple Sclerosis, Relapsing-Remitting
United States
- Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisActive Not Recruiting
Sponsor: Sanofi
Multiple Sclerosis
United States, Argentina, Austria, Belgium, Brazil +36 more
Sponsor: Shionogi
Amyotrophic Lateral Sclerosis (ALS)
United States, Canada, France, Germany, Italy +1 more
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis · Multiple Sclerosis
United States, Puerto Rico
Sponsor: Hoffmann-La Roche
Relapsing Remitting Multiple Sclerosis
United States, Germany, Spain
- Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)Active Not Recruiting
Sponsor: Zura Bio Inc
Systemic Sclerosis (SSc) · Scleroderma
United States, Argentina, Chile, Hungary, Mexico +5 more
- Ocrevus Zunovo for MS: Mixed MethodsRecruiting
Sponsor: Northwestern University
Multiple Sclerosis
United States
Sponsor: TG Therapeutics, Inc.
B-cell Mediated Autoimmune Disorders
United States
- Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple SclerosisRecruiting
Sponsor: MGH Institute of Health Professions
Multiple Sclerosis
United States
Sponsor: Johns Hopkins University
Multiple Sclerosis
United States
Sponsor: Tiffany J. Braley, MD, MS
Multiple Sclerosis · Sleep · Pain
United States
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Cystic Fibrosis · Pulmonary Fibrosis · Tuberous Sclerosis · Asthma
United States
- Effects Of Motor Imagery and Sensorimotor TrainingNot Yet Recruiting
Sponsor: Uludag University
Multiple Sclerosis
Turkey (Türkiye)
Sponsor: Texas Woman's University
Multiple Sclerosis
United States
- A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple SclerosisActive Not Recruiting
Sponsor: Genentech, Inc.
Multiple Sclerosis
United States
- Validation and Standardization of Paramagnetic Rim Lesion (PRL) Identification in Multiple Sclerosis Across MAGNIMS CentersActive Not Recruiting
Sponsor: IRCCS San Raffaele
Multiple Sclerosis
Austria, Czechia, Denmark, Germany, Italy +6 more
Sponsor: Janssen Research & Development, LLC
Relapsing Remitting Multiple Sclerosis
United States
- A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Relapsing-remitting Multiple Sclerosis
United States, Argentina, Australia, Austria, Belgium +20 more
- Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic ToolNot Yet Recruiting
Sponsor: King's College London
Optic Neuritis · Multiple Sclerosis · Neuromyelitis Optica Spectrum Disorder · Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders
United Kingdom